Albireo Pharma Inc (ALBO) Insider Trading
- $30,497,757.32
- $24,910,009.42
- Jan. 23, 2023
- Pamela Stephenson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 23, 2023 | CEO | 1,057 | $43.80 | Sell | $46,296.60 | |
Jan. 23, 2023 | Insider | 102 | $43.80 | Sell | $4,467.60 | |
Jan. 19, 2023 | CFO | 1,776 | $43.80 | Sell | $77,788.80 | |
Jan. 19, 2023 | Insider | 938 | $43.90 | Sell | $41,178.20 | |
Dec. 27, 2022 | Insider | 469 | $19.06 | Sell | $8,939.14 | |
Oct. 24, 2022 | Insider | 104 | $19.58 | Sell | $2,036.32 | |
Oct. 24, 2022 | CEO | 919 | $19.58 | Sell | $17,994.02 | |
Oct. 13, 2022 | Major Shareholder | 179,132 | $22.01 | Sell | $3,942,695.32 | |
Oct. 11, 2022 | CFO | 80 | $23.79 | Sell | $1,903.20 | |
Oct. 11, 2022 | Major Shareholder | 144,065 | $23.54 | Sell | $3,391,290.10 | |
Sept. 26, 2022 | Insider | 445 | $19.40 | Sell | $8,633.00 | |
July 25, 2022 | Insider | 313 | $23.88 | Sell | $7,474.44 | |
July 22, 2022 | CEO | 929 | $24.67 | Sell | $22,918.43 | |
July 22, 2022 | Insider | 205 | $24.68 | Sell | $5,059.40 | |
July 22, 2022 | CFO | 106 | $24.67 | Sell | $2,615.02 | |
July 12, 2022 | CFO and Treasurer | 95 | $24.03 | Sell | $2,282.85 | |
June 27, 2022 | Insider | 461 | $19.47 | Sell | $8,975.67 | |
April 25, 2022 | Insider | 312 | $33.43 | Sell | $10,430.16 | |
April 22, 2022 | Insider | 103 | $32.92 | Sell | $3,390.76 | |
April 22, 2022 | CEO | 907 | $33.11 | Sell | $30,030.77 | |
April 11, 2022 | CFO | 96 | $35.74 | Sell | $3,431.04 | |
March 28, 2022 | Insider | 454 | $30.52 | Sell | $13,856.08 | |
Jan. 24, 2022 | CFO | 416 | $24.88 | Sell | $10,350.08 | |
Jan. 24, 2022 | Insider | 1,688 | $24.94 | Sell | $42,098.72 | |
Jan. 24, 2022 | CEO | 3,684 | $24.88 | Sell | $91,657.92 | |
Jan. 11, 2022 | CFO | 111 | $25.95 | Sell | $2,880.45 | |
Dec. 27, 2021 | Insider | 474 | $23.92 | Sell | $11,338.08 | |
Oct. 25, 2021 | Insider | 217 | $29.21 | Sell | $6,338.57 | |
Oct. 22, 2021 | Insider | 95 | $28.83 | Sell | $2,738.85 | |
Sept. 27, 2021 | Insider | 451 | $32.05 | Sell | $14,454.55 | |
July 22, 2021 | Insider | 90 | $34.13 | Sell | $3,071.70 | |
July 13, 2021 | CFO | 98 | $35.02 | Sell | $3,431.96 | |
June 25, 2021 | insider | 471 | $36.01 | Sell | $16,960.71 | |
April 22, 2021 | Insider | 90 | $31.75 | Sell | $2,857.50 | |
April 12, 2021 | CFO | 92 | $32.12 | Sell | $2,955.04 | |
April 1, 2021 | Insider | 300 | $36.16 | Sell | $10,848.00 | |
March 29, 2021 | Insider | 422 | $34.02 | Sell | $14,356.44 | |
March 3, 2021 | Insider | 31,470 | $36.85 | Sell | $1,159,669.50 | |
Jan. 22, 2021 | Insider | 110 | $34.62 | Sell | $3,808.20 | |
Jan. 11, 2021 | CFO | 110 | $37.33 | Sell | $4,106.30 | |
Dec. 28, 2020 | Insider | 460 | $39.07 | Sell | $17,972.20 | |
Oct. 22, 2020 | Insider | 89 | $34.55 | Sell | $3,074.95 | |
Sept. 25, 2020 | Insider | 451 | $33.20 | Sell | $14,973.20 | |
Sept. 14, 2020 | Major Shareholder | 400,000 | $40.00 | Buy | $16,000,000.00 | |
Sept. 11, 2020 | Insider | 10,000 | $40.03 | Sell | $400,300.00 | |
Sept. 9, 2020 | Insider | 10,000 | $38.97 | Sell | $389,700.00 | |
July 22, 2020 | Insider | 91 | $25.80 | Sell | $2,347.80 | |
July 10, 2020 | CFO | 92 | $25.56 | Sell | $2,351.52 | |
June 25, 2020 | Insider | 397 | $30.79 | Sell | $12,223.63 | |
April 22, 2020 | Insider | 92 | $17.64 | Sell | $1,622.88 |
Insiders are both buying and selling Albireo Pharma Inc stock.
The insider traders at Albireo Pharma Inc are: Pamela Stephenson, Simon N.R. Harford, Jason Duncan, Ronald Harold Wilfred Cooper, Patrick Taylor Horn, Martha J Carter, Jan Mattsson, Perceptive Advisors Llc, Life Sciences Maste Perceptive, Brian Jg Pereira, Phase4 Partners Ltd, Plc Astrazeneca, and Harford Simon N.R.
The most active insider trader at Albireo Pharma Inc is Pamela Stephenson with 14 trades.
Plc Astrazeneca has sold the most Albireo Pharma Inc stock with a total value of $21,400,000.00.
Life Sciences Maste Perceptive has bought the most Albireo Pharma Inc stock with a total value of $41,075,000.00.
The most recent insider trade for Albireo Pharma Inc was on Jan. 23, 2023.
The single biggest insider buy for Albireo Pharma Inc was from Life Sciences Maste Perceptive with a total value of $16,000,000.00 on Sept. 14, 2020.
The single biggest insider sell for Albireo Pharma Inc was from Plc Astrazeneca with a total value of $10,700,000.00 on Dec. 1, 2017.